You are invited to take part in this clinical trial because currently, there is no approved vaccine for the prevention of acute gastroenteritis (AGE) caused by norovirus. Acute gastroenteritis, commonly known as the stomach flu or stomach bug, is characterized by symptoms such as nausea, vomiting, diarrhea, abdominal cramps, and sometimes fever. The purpose of this clinical trial is to evaluate an investigational vaccine to prevent AGE caused by a norovirus infection.
We are doing this research trial to find out more about an investigational vaccine called mRNA-1189 that is being tested to see if it gives protection from a virus called Epstein-Bar Virus, or EBV for short. EBV is a very common virus that is spread from person to person by close contact beginning in childhood. By age 24, about 90% of people will have already had an EBV infection, however most people show no symptoms. EBV is also the main cause of an illness called infectious mononucleosis (IM), or “mono” for short.
